3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Frailty
5
Neoplasms
3
Lung Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Carcinoma, Non-Small-Cell Lung
2
Urogenital Neoplasms
1
Solid Neoplasm
1
Sarcopenia
1
Sarcoma
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Hepatic Malignancies
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Health Education
1
Head and Neck Neoplasms
1
Communication
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Doxorubicin
26
pembrolizumab
24
Radiotherapy
20
Cyclophosphamide
18
Magnetic Resonance Spectroscopy
17
Specimen Handling
14
Nivolumab
14
Gemcitabine
13
Ifosfamide
12
Surgical Procedures, Operative
11
Biopsy
11
Radiation
10
X-Rays
8
Temozolomide
8
Ipilimumab
8
pazopanib
7
fludarabine
7
cabozantinib
7
Irinotecan
7
tazemetostat
6
liposomal doxorubicin
6
Trabectedin
6
Surveys and Questionnaires
6
Phantoms, Imaging
6
Blood Specimen Collection
6
olaparib
5
eribulin
5
atezolizumab
5
anlotinib
5
Vincristine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Geriatric Assessment
×
1 year
×
Clear all
NCT03077178
2026-01-30
SARCOLD
Institut Bergonié
Phase NA
Active not recruiting
25 enrolled